FN2 Earnings Intelligence
MRSH revenue earnings history
Marsh & McLennan Companies, Inc. (MRSH) quarterly reported and estimated revenue history by fiscal quarter.
Earnings History
Marsh & McLennan Companies, Inc.
Marsh & McLennan posted a solid Q2 2026, with revenue rising 6% year-over-year to $7.4 billion and adjusted EPS up 9% to $2.96, edging past the $2.88 consensus. Underlying revenue growth accelerated to 5% from 4% in Q1, a notable signal given persistent softness in property and reinsurance pricing. The Thrive program, an ongoing brand unification (Guy Carpenter and Mercer will transition to the Marsh brand in September), and a deepening AI toolkit including the newly launched LenWork LLM assistant are collectively driving productivity and new-business momentum. Record catastrophe-bond issuance ($5 billion across 20 deals in H1) and digital-infrastructure solutions for energy and data-center clients are helping offset pricing headwinds. The market's initial response was lukewarm: the stock underperformed its benchmark by roughly 1.1% on the report session. However, shares subsequently…
Marsh & McLennan Companies, Inc.
Marsh's Q1 print shows a business able to grow adjusted EPS and expand margins even as insurance and reinsurance pricing compresses, aided by AI-driven productivity, an active acquisition pipeline (AltamarCAM) and steady capital returns. The test over the coming year is whether underlying revenue growth near 4% and margin expansion can outpace falling pricing, lower fiduciary income and the drag from the $425M litigation charge.
Marsh & McLennan Companies, Inc.
The supplied analysis supports a constructive but conditional view: resilient demand, margin expansion, and investment in AI and digital infrastructure support the growth case, while rate declines and talent risks are important offsets.
Marsh & McLennan Companies, Inc.
The quarter supports a constructive operating thesis: acquisition contributions, risk-advisory demand and analytics investments are supporting growth. The counterweight is that insurance pricing pressure and litigation risks could constrain the pace and quality of future expansion.
Marsh & McLennan Companies, Inc.
The quarter supports a constructive but qualified view: broad underlying growth, acquisition integration and resilience-related demand provide support, while tariff uncertainty, insurance-rate changes, catastrophe exposure and M&A risks remain important tests.
Get the MRSH recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.